Microsurgical Techniques Used to Construct the Vascularized and Neurotized Tissue Engineered Bone

Fan, Junjun; Bi, Long; Jin, Dan; Wei, Kuanhai; Chen, Bin; Zhang, Zhiyong; Pei, Guoxian

doi:https://doi.org/10.1155/2014/281872

BioMed Research International

On this page

Abstract Introduction Conclusion Acknowledgments References Copyright Related Articles

Review Article Letter to the Editor

!

A Letter to the Editor for this article has been published. To view the article details, please click the ‘Letter to the Editor’ tab above.

Special Issue

Bone Tissue Engineering: Cell Motility, Vascularization, Micro-Nano Scaffolding and Remodeling

View this Special Issue

Review Article | Open Access

Volume 2014 | Article ID 281872 | https://doi.org/10.1155/2014/281872

Microsurgical Techniques Used to Construct the Vascularized and Neurotized Tissue Engineered Bone

Junjun Fan,¹Long Bi,¹Dan Jin,²Kuanhai Wei,²Bin Chen,²Zhiyong Zhang,³and Guoxian Pei¹

Academic Editor: Yi Xian Qin

Received03 Apr 2014

Accepted02 May 2014

Published13 May 2014

Abstract

The lack of vascularization in the tissue engineered bone results in poor survival and ossification. Tissue engineered bone can be wrapped in the soft tissue flaps which are rich in blood supply to complete the vascularization in vivo by microsurgical technique, and the surface of the bone graft can be invaded with new vascular network. The intrinsic vascularization can be induced via a blood vessel or an arteriovenous loop located centrally in the bone graft by microsurgical technique. The peripheral nerve especially peptidergic nerve has effect on the bone regeneration. The peptidergic nerve can be used to construct the neurotized tissue engineered bone by implanting the nerve fiber into the center of bone graft. Thus, constructing a highly vascularized and neurotized tissue engineered bone according with the theory of biomimetics has become a useful method for repairing the large bone defect. Many researchers have used the microsurgical techniques to enhance the vascularization and neurotization of tissue engineered bone and to get a better osteogenesis effect. This review aims to summarize the microsurgical techniques mostly used to construct the vascularized and neurotized tissue engineered bone.

1. Introduction

It is a big challenge for surgeons to repair the large bone defect caused by the trauma, infection, tumor, or other reasons. Autologous bone grafting is considered as the golden standard for the clinical treatment of bone defects [1–5], but there are many problems such as new wound to the donor site, limited source of autologous bone, and high risk of infection. In recent few decades, bone tissue engineering has developed very fast which gives us the hope to solve this problem. But there are still many problems with the clinical application of tissue engineered bone. Bone tissue is a highly vascularized tissue and the bone cells need sufficient blood supply to maintain their nutrition [6]. Before the vascularization completed, the implanted bone graft gets nutrition mainly through the osmosis of interstitium fluid and only 100–300 μm thickness under the bone graft surface can get nutrition. The seed cells such as bone marrow stem cells in the center of the bone graft will lack enough nutrition and finally die. The osteogenesis is influenced by the process of vascularization and this limits the clinical application of tissue engineered bone. Over the last few years, many researchers have used the microsurgical techniques to enhance the vascularization of tissue engineered bone and get a better reparative effect in bone defect [7–10]. Tissue engineered bone grafts can be wrapped in the soft tissue flaps such as pedicle fascia flap, muscle flap, or periosteum flap to complete the vascularization in vivo by microsurgical technique and the surface of bone graft can be invaded with new vascular networks. The intrinsic vascularization can be induced via a blood vessel or an arteriovenous loop being implanted centrally in the bone graft by microsurgical technique. Our group also has successfully enhanced the vascularization of tissue engineered bone using these microsurgery techniques in many kinds of animal models from little animals such as rabbit to large animals such as goat and rhesus [11–13]. Besides the vascular networks, bone tissues also have abundant neural network distributed in the areas such as periosteum, marrow cavity, and bone cortex. The neural fibers also contact with the bone cells and medullary cells [14]. The peripheral nerve especially peptidergic nerve has the ability to regulate the function of osteoblasts and blood vessels [15–18]. So constructing the neurotized tissue engineered bone is very important to improve the reparative effect in bone defect. Our research group has successfully used the microsurgical techniques to achieve the neurotization of tissue engineered bone in vivo and improved the reparative effect on the bone defect [19–21]. We also have given the concept of constructing the highly vascularized and neurotized tissue engineered bone simultaneously by microsurgical techniques for repairing large bone defects according with the theory of biomimetics. This review aims to summarize the applications of microsurgical techniques mostly used to construct the vascularized and neurotized tissue engineered bone and to introduce our relative researches about this section.

2. Microsurgical Techniques Used for Vascularization

2.1. Tissue Flaps

Tissue flaps such as fascia flap, muscle flap, and peritoneum flap have rich blood supply and can be used as the vascular bed to enhance the vascularization of tissue engineered bone [22–24]. Before implanting the tissue engineered bone to the bone defect, we can wrap the bone graft in suitable tissue flap which is rich in blood supply to achieve the ectopic vascularization and osteogenesis at first and then implant the bone graft to the bone defect site with a reoperation [25–29]. Although this technique is feasible for the vascularization of tissue engineered bone, the pattern of new vascular network within the implanted bone graft is random, and the reoperation of bone graft to the bone defect site is impossible without damaging the initial vascular network [30]. To avoid the reoperation and shorten the treatment time, the vascular pedicled flaps such as pedicled fascia flap, pedicled muscle flap, and pedicled periosteum flap are used to achieve the vascularization of tissue engineered bone graft in vivo. These vascular pedicled flaps can be transferred to the bone defect site by microsurgical technique and wrap the tissue engineered bone in situ to achieve the vascularization without reoperation. Compared with the first method of ectopic vascularization, the method of vascularization in situ can shorten the treatment time and need no reoperation but is limited by the local circumstance of the bone defect site. Both methods need excellent microsurgical techniques.

There are several kinds of soft tissue flap that can be used to enhance the vascularization of tissue engineered bone. Fascia flap, muscle flap, and periosteum flap are the most commonly used to wrap the bone graft.

Fascia flap has rich capillary network and excellent permeability as a most suitable soft tissue flap for enhancing the vascularization. Our group is the first to report the use of fascia flap to enhance the vascularization of tissue engineered bone in the large animal model of goat. We found that pedicled fascia flap could accelerate the revascularization and osteogenesis process of tissue engineered bone in large animal model [12]. Liu et al. observed the bone formation using beagle deep fascia pedicled flap wrapping the tissue engineered bone and they found that the new blood vessels of tissue engineered bone in the fascia flap group were superior to those in the control group, suggesting that pedicled fascia flap could promote the revascularization of tissue engineered bone in vivo [31]. Yang et al. reported that the tissue engineered bone wrapped by the pedicled fascial flap had a sound reparative effect on bone defect due to its dual role of constructing vascularization and inducing membrane guided tissue regeneration [32].

Muscle flap also has rich blood supply and is usually used to repair the soft tissue defect or infected wound in clinical patients. The latissimus dorsi muscle is the most commonly used to wrap the tissue engineered bone. Casabona implanted a porous hydroxyapatite ceramic scaffold with the human bone marrow stromal cells into the latissimus dorsi of athymic mice and found the presence of new spongious bone tissue [33]. Terheyden used the xenogenic bone mineral as the bone scaffold and implanted it into a pouch prepared in the latissimus dorsi muscle of minipig. They found a large number of newly formed bone tissues and vascular networks [34]. Warnke implanted a custom bone graft into the latissimus dorsi muscle of an adult male patient and successfully repaired the mandibular bone defect of the patient [35].

Periosteum flap also has rich blood supply and can be used to induce bone regeneration. There are many reports about using the periosteum or cultured periosteal cells to enhance the osteogenesis and vascularization of tissue engineered bone [36–45]. A vascularized periosteal flap contains osteoprogenitor cells, structural matrix, and many kinds of growth factors such as bone morphogenetic protein. Vögelin et al. constructed a vascularized bone graft by using a periosteal flap in a rat model and found significant new bone tissue and vascular network formed in the tissue engineered bone [46]. But the periosteal flap is hard to obtain and difficult to wrap large scale of bone graft.

Although tissue engineered bone grafts can be wrapped in the soft tissue flaps which are rich in blood supply to enhance the vascularization in vivo by microsurgical techniques, only the surface of bone graft can be invaded with new vascular networks and the pattern of the new blood vessels is random. The intrinsic vascularization of bone graft is still not achieved with this method of soft tissue flap wrapping.

2.2. Axial Blood Vessel

The intrinsic vascularization can be induced via a blood vessel located centrally in the bone graft by microsurgical technique. There are many reports about the use of the carotid artery, jugular vein, and saphenous vascular bundle in biomaterials resulting in splendid osteogenesis and vascularization of the bone grafts [47–50]. Surgeons can embed a suitable axial blood vessel into the center of bone graft to get a vascularized bone tissue and then transfer the vascularized bone graft to the bone defect site using microsurgical vascular anastomosis. Similar to free pedicled flaps, the implanted bone graft can be immediately vascularized. Cassell et al. reported that there were plenty of capillary collateral newborns to build the capillary network when the blood vessel was stimulated. This method has been used in the clinical cases to treat the patients with ischemic necrosis of femoral head and the wrist scaphoid nonunion, and it showed the positive results [51]. Pelissier et al. reported that embedding a vascular pedicle in the coralline scaffold could enhance the vascularization and osteogenesis after being implanted in ectopic intramuscular sites [52]. Our group also used this method of implanting blood vessel into the center of tissue engineered bone to enhance the vascularization and osteogenesis in many animal models from little animals such as rabbit to large animals such as rhesus [11, 13]. As we know, we are the first to report the use of blood vessel to enhance the vascularization of tissue engineered bone in a primate animal model of rhesus by microsurgical techniques and our research proves the feasibility of this method to be used in clinical patients.

2.3. Arteriovenous Loop

Although the method of embedding axial blood vessel is available for enhancing the intrinsic vascularization of tissue engineered bone, the clinical application may be limited by the length and anatomic location of blood vessel. So a new method of arteriovenous (AV) loop has been used to enhance the intrinsic vascularization. This AV loop has been proved to be superior compared to the axial blood vessel both in terms of neovascular density and capacity [53]. This method was firstly described by Erol and Spira, and they successfully constructed a prefabricated full-thickness skin graft in a rat model by using the arteriovenous vessel loop. Significant neovascular network was observed originating from the AV loop [54]. Cassell et al. implanted the arteriovenous loop into polycarbonate isolation chambers and they successfully constructed the axially vascularized tissue by inducing vascularization in polymer matrices [55]. Arkudas et al. reported that using an arteriovenous loop could promote the survival and differentiation of transplanted autologous osteoblasts [56]. The AV loop has minimal morbidity of donor site and can be created at any surgical site without regarding the vascular pedicle length. Ren hypothesized that a combination of cells, biomaterials, growth factors, and arteriovenous loop may be able to generate a large and vascularized tissue engineered bone in vivo eventually [57].

Like autologous bone grafts, the new vascularized bone graft can be transferred to the bone defect site using the microsurgical techniques. This method of embedding blood vessel or AV loop will facilitate the clinical application of tissue engineered bone and offer new therapeutic strategies for reconstruction of large bone defects.

3. Microsurgical Techniques Used for Neurotization

3.1. The Important Role of Neurotization

Bone tissue is not only a highly vascularized tissue but also a highly neurotized tissue. By the anatomy study of the bone tissue, many researches have proved that there were dense and intimate networks of nerve in the bone tissue and the nerve networks had contact with bone cells [58–62]. Our group also found that there were many nerve fibers in human bone tissue distributed in the periosteum, cortical bone, cancellous bone, and bone marrow [63]. Then many researchers found the intimate relationship between the bone formation and the nerve networks development and proved that nerve networks played a very important role in the process of bone formation [64–66]. The mechanism about how the nerve networks act on the bone tissue was studied by many researchers. Bjurholm observed the features of the nerve fibers in bone tissue and showed that they were mainly peptidergic nerve fibers and had a neuroendocrine influence on bone physiology [67]. Hill et al. further reported that the peptidergic nerve fibers mainly accompanied blood vessels, and a few nerve endings stretched out and stopped in other locations such as the periosteum cell layer or bone marrow cells including osteoblasts and osteoclasts and released neuropeptides to regulate the bone physiology [68–70]. The finding that both osteoblasts and osteoclasts expressed functional neuropeptide receptors further proved the important role of nerve network in bone regeneration [71]. These neuropeptides including calcitonin gene-related peptide (CGRP) and nerve peptide Y (NPY) enhance osteoblast proliferation in vitro and inhibit the bone resorbing activity of isolated osteoclasts by regulating different cytokines pathways [72–79]. These neuropeptides are also associated with the dilation and the constrictor of blood vessels through interaction with neuropeptide receptors that are present on the wall of blood vessel via endothelium-dependent or endothelium-independent mechanisms, depending on the blood vessel type [80–85]. Blood vessels in the bone are innervated by the autonomic nervous system and sensory nerve fibers to regulate the blood flow [86], and sensory neuropeptides participate in the regulation of angiogenesis [87]. So these neuropeptides have ability to regulate the function of osteoblasts and to control the blood flow, and this can explain why it is very important to construct the nerve networks in tissue engineered bone to improve the effect of bone formation.

3.2. Nerve Tracts

The ability of the peptidergic nerve fiber to regulate the function of osteoblasts and blood vessels can be used to construct the neurotized tissue engineered bone by embedding the nerve fiber into the center of bone graft [19–21]. As we know, our group is the first in the world to successfully construct the neurotized tissue engineered bone by microsurgery techniques and repair the large bone defect in animal model. We implanted the sensory nerve tract or motor nerve tract into the side groove of β-TCP scaffold to repair a 1.5 cm femur defect in the rabbit. The values of bone mineral density and the neuropeptide were significantly higher in sensory nerve group compared with the motor never group and the blank group. But the ossification and nervalization effects of motor nerve group showed no significant difference compared with that of blank group [21]. Our group also investigated the effect of saphenous nerve and sciatic nerve homogenates on the proliferation and calcification of rabbit osteoblasts in vitro. We found that saphenous nerve homogenates significantly promoted the proliferation, differentiation, ALP activity, and mineralization of rabbit osteoblasts, but sciatic nerve homogenates did not show any osteogenic effect on the cells [88]. These results showed that the osteogenesis and neurotization of tissue engineered bone were more closely related to sensory nerves. By implanting the tissue engineered bone with sensory nerve tracts or blood vessels to repair a 1.5 cm femur defect in the rabbit, we found that implanting sensory nerve tracts or blood vessels into tissue engineered bone, respectively, could both improve the osteogenesis and the early expression of neuropeptides [20]. Although the group with sensory nerve tracts showed a little weaker effect compared to the vascular group, embedding nerve tracts into the tissue engineered bone could still improve the neurotization and osteogenesis of the bone graft compared to those in blank group. And this result may relate to the neuropeptides originated from the implanted sensory nerve. In our study, the saphenous nerve tract was separated and cut from the distal end in order to make the distal end of the nerve free, and then it was implanted into the side groove of the β-TCP scaffold. This method could make the neuropeptide, which was produced by the neurons, release from the distal end more easily, and it acted on the BMSCs via its receptors to regulate the metabolism of the bone.

Our group also evaluated the different effects on the expression of calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) between tissue engineered bone with blood vessel in vivo or with sensory nerve tract. We found implantation of blood vessel into tissue engineered bone could significantly improve the expressions of CGRP and NPY at the early 3 months compared with implantation of sensory tract into tissue-engineered bone, but the differences were not significant at 6 or 12 months postoperatively [19]. We also investigated whether the implantation of blood vessel and sensory nerve tract could affect the expressions of neurokinin 1 receptor (NK1R) and vasoactive intestinal peptide type 1 receptor (VIPR1). We found that both blood vessel and sensory nerve could significantly improve the expression levels of NK1R and VIPR1 compared with the blank group [89]. Our researches showed that both sensory nerve tracts and blood vessel could be used to construct the neurotized tissue engineered bone.

Although sensory nerves can enhance the osteogenesis of tissue engineered bone, the neurocyte also needs the oxygen and nutrients. The neurotization of tissue engineered bone needs the vascularization as the preconditions. Masaki connected a silicone gel tube to the sciatic nerves of mice and then placed a small artery that was adjacent to the sciatic nerve into the silicone gel tube through a longitudinal incision to provide oxygen and nutrients to the regenerated nerve [90]. The improved microenvironment in the silicone tube produced good regeneration results. Palmer inferred that neurogenesis generally occurred near blood vessels because of the satisfactory vascular microenvironment with sufficient blood supply [91]. Meanwhile, blood vessels in the bone are also innervated by the autonomic nervous system and sensory nerve fibers to regulate blood flow, and sensory neuropeptides participate in the regulation of angiogenesis [86, 87]. So there is highly intimate relationship between the blood vessel and nerve networks in the bone tissue. When constructing tissue engineered bone, it is important to ensure adequate blood supply and perfect innervation to promote survival of the bone graft. As we know, our group is the first to give the concept of constructing the highly vascularized and neurotized tissue engineered bone simultaneously according with the theory of biomimetics by microsurgery techniques. It may be a dramatic method to construct the vascularized and neurotized tissue engineered bone simultaneously by implanting both blood vessel and the sensor nerve tract into the center of bone graft with microsurgery techniques.

4. Conclusion

The lack of vascularization and neurotization within the tissue engineered bone results in poor ossification and limits the clinical application of tissue engineered bone. The vascularization of bone grafts can be promoted by soft tissue flap wrapping, blood vessel embedding, and arteriovenous loop embedding centrally in vivo by microsurgical techniques, but this method has the disadvantage of uncertain neurotization effect. The neurotization of bone grafts can be promoted by peptidergic nerve tract embedding centrally in vivo by microsurgical techniques, but this method also has the disadvantage of uncertain vascularization effect. So each method has the superiority and disadvantage. Combination of different methods will be necessary and useful to improve the reparative effect of tissue engineered bone in the large bone defect. We give the concept of constructing the highly vascularized and neurotized tissue engineered bone simultaneously by microsurgical techniques according with the theory of biomimetics. The microsurgical techniques will play a more and more important role in the development of bone tissue engineering and eventually achieve the wide clinical application of tissue engineered bone to repair the bone defect of patients.

Conflict of Interests

The authors declare that they have no conflict of interests associated with this paper.

Authors’ Contribution

Junjun Fan and Long Bi contributed equally to this paper.

Acknowledgments

This study was supported by the National Natural Science Foundation of China (Grants nos. 81272011 and 81301569) and the National 863 Project of China (Grant no. 2012AA020502-6).

References

M. K. Sen and T. Miclau, “Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?” Injury, vol. 38, no. 1, pp. S75–S80, 2007.
View at: Publisher Site | Google Scholar
W. Waked and J. Grauer, “Silicates and bone fusion,” Orthopedics, vol. 31, no. 6, pp. 591–597, 2008.
View at: Publisher Site | Google Scholar
A. Mahendra and A. Maclean, “Available biological treatments for complex non-unions,” Injury, vol. 38, no. 4, pp. S7–S12, 2007.
View at: Publisher Site | Google Scholar
S. Chugh, D. S. Marks, D. C. Mangham, and A. G. Thompson, “Autologous bone grafting in staged scoliosis surgery: the patient as bone bank,” Spine, vol. 23, no. 16, pp. 1793–1795, 1998.
View at: Publisher Site | Google Scholar
E. L. Burger and V. Patel, “Calcium phosphates as bone graft extenders,” Orthopedics, vol. 30, no. 11, pp. 939–942, 2007.
View at: Google Scholar
J. M. Kanczler and R. O. C. Oreffo, “Osteogenesis and angiogenesis: the potential for engineering bone,” European Cells and Materials, vol. 15, pp. 100–114, 2008.
View at: Google Scholar
K. Kawamura, H. Yajima, H. Ohgushi et al., “Experimental study of vascularized tissue-engineered bone grafts,” Plastic and Reconstructive Surgery, vol. 117, no. 5, pp. 1471–1479, 2006.
View at: Publisher Site | Google Scholar
U. Kneser, E. Polykandriotis, J. Ohnolz et al., “Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop,” Tissue Engineering, vol. 12, no. 7, pp. 1721–1731, 2006.
View at: Publisher Site | Google Scholar
A. Hokugo, Y. Kubo, Y. Takahashi et al., “Prefabrication of vascularized bone graft using guided bone regeneration,” Tissue Engineering, vol. 10, no. 7-8, pp. 978–986, 2004.
View at: Publisher Site | Google Scholar
A. Arkudas, J. P. Beier, K. Heidner et al., “Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts,” Tissue Engineering, vol. 13, no. 7, pp. 1549–1560, 2007.
View at: Publisher Site | Google Scholar
L. Wang, H. Fan, Z.-Y. Zhang et al., “Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized β-tricalcium phosphate scaffold and mesenchymal stem cells,” Biomaterials, vol. 31, no. 36, pp. 9452–9461, 2010.
View at: Publisher Site | Google Scholar
B. Chen, G.-X. Pei, K. Wang, D. Jin, K.-H. Wei, and G.-H. Ren, “The method of accelerating osteanagenesis and revascularization of tissue engineered bone in big animal in vivo,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 25, no. 1, pp. 26–31, 2003.
View at: Google Scholar
X.-M. Wang, G.-X. Pei, D. Jin, K.-H. Wei, S. Jiang, and G.-H. Tang, “Perfusion-weighted magnetic resonance imaging for monitoring vascularization in tissue-engineered bone in rhesuses,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 26, no. 7, pp. 931–935, 2006.
View at: Google Scholar
C. M. Serre, D. Farlay, P. D. Delmas, and C. Chenu, “Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers,” Bone, vol. 25, no. 6, pp. 623–629, 1999.
View at: Publisher Site | Google Scholar
E. Tanaka, Y. Ishino, A. Sasaki et al., “Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity,” Annals of Biomedical Engineering, vol. 34, no. 5, pp. 717–725, 2006.
View at: Publisher Site | Google Scholar
S. C. Offley, T.-Z. Guo, T. Wei et al., “Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity,” Journal of Bone and Mineral Research, vol. 20, no. 2, pp. 257–267, 2005.
View at: Publisher Site | Google Scholar
F. Elefteriou, “Regulation of bone remodeling by the central and peripheral nervous system,” Archives of Biochemistry and Biophysics, vol. 473, no. 2, pp. 231–236, 2008.
View at: Publisher Site | Google Scholar
U. H. Lerner and E. Persson, “Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide,” Journal of Musculoskeletal Neuronal Interactions, vol. 8, no. 2, pp. 154–165, 2008.
View at: Google Scholar
J.-D. Cui, G.-X. Pei, and S. Jiang, “A study of the different effect on the expression of calcitonin gene related peptide and neuropeptide Y in tissue engineered bone with vascular bundle graft in vivo and that with sensory nerve tract graft in vivo,” Zhonghua Wai Ke Za Zhi, vol. 46, no. 16, pp. 1249–1252, 2008.
View at: Google Scholar
S.-Y. Chen, J.-J. Qin, L. Wang et al., “Different effects of implanting vascular bundles and sensory nerve tracts on the expression of neuropeptide receptors in tissue-engineered bone in vivo,” Biomedical Materials, vol. 5, no. 5, Article ID 055002, 2010.
View at: Publisher Site | Google Scholar
S. Jiang, Y. Liu, Q. Wang et al., “Experimental study on construction of neurotization tissue engineered bone for repairing large bone defects in rabbit,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 24, no. 5, pp. 599–605, 2010.
View at: Google Scholar
U. Kneser, A. Voogd, J. Ohnolz et al., “Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute,” Cells Tissues Organs, vol. 179, no. 4, pp. 158–169, 2005.
View at: Publisher Site | Google Scholar
J. P. Beier, U. Kneser, J. Stern-Sträter, G. B. Stark, and A. D. Bach, “Y chromosome detection of three-dimensional tissue-engineered skeletal muscle constructs in a syngeneic rat animal model,” Cell Transplantation, vol. 13, no. 1, pp. 45–53, 2004.
View at: Google Scholar
U. Kneser, P. M. Kaufmann, H. C. Fiegel et al., “Long-term differentiated function of heterotopically transplanted hepatocytes on three dimensional polymer matrices,” Journal of Biomedical Materials Research, vol. 47, no. 4, pp. 494–503, 1999.
View at: Google Scholar
J. Schipper, G. J. Ridder, W. Maier, and R. E. Horch, “The preconditioning and prelamination of pedicled and free microvascular anastomised flaps with the technique of vacuum assisted closure,” Laryngo-Rhino-Otologie, vol. 82, no. 6, pp. 421–427, 2003.
View at: Publisher Site | Google Scholar
R. K. Khouri, J. Upton, and W. W. Shaw, “Principles of flap prefabrication,” Clinics in Plastic Surgery, vol. 19, no. 4, pp. 763–771, 1992.
View at: Google Scholar
N. Kimura, T. Hasumi, K. Satoh, and N. A. Fine, “Prefabricated thin flap using the transversalis fascia as a carrier,” Plastic and Reconstructive Surgery, vol. 108, no. 7, pp. 1972–1980, 2001.
View at: Google Scholar
R. K. Khouri, J. Upton, and W. W. Shaw, “Prefabrication of composite free flaps through staged microvascular transfer: an experimental and clinical study,” Plastic and Reconstructive Surgery, vol. 87, no. 1, pp. 108–115, 1991.
View at: Google Scholar
E.-H. A. Abbase, S. M. Shenaq, M. Spira, and M. H. El-Falaky, “Prefabricated flaps: experimental and clinical review,” Plastic and Reconstructive Surgery, vol. 96, no. 5, pp. 1218–1225, 1995.
View at: Google Scholar
U. Kneser, D. J. Schaefer, E. Polykandriotis, and R. E. Horch, “Tissue engineering of bone: the reconstructive surgeon's point of view,” Journal of Cellular and Molecular Medicine, vol. 10, no. 1, pp. 7–19, 2006.
View at: Publisher Site | Google Scholar
W. Liu, Y. Aihemaitijiang, and Y.-F. Chen, “Repair of beagle canine defects with fascia-encapsulated bone marrow mesenchymal stem cells/poly-lactone complex,” Journal of Clinical Rehabilitative Tissue Engineering Research, vol. 14, no. 7, pp. 1146–1151, 2010.
View at: Publisher Site | Google Scholar
X. Yang, W. Shi, Y. Du, X. Meng, and Y. Yin, “Experimental study of repairing bone defect with tissue engineered bone seeded with autologous red bone marrow and wrapped by pedicled fascial flap,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 23, no. 10, pp. 1254–1259, 2009.
View at: Google Scholar
F. Casabona, I. Martin, A. Muraglia et al., “Prefabricated engineered bone flaps: an experimental model of tissue reconstruction in plastic surgery,” Plastic and Reconstructive Surgery, vol. 101, no. 3, pp. 577–581, 1998.
View at: Publisher Site | Google Scholar
H. Terheyden, C. Knak, S. Jepsen, S. Palmie, and D. R. Rueger, “Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part I: prefabrication,” International Journal of Oral and Maxillofacial Surgery, vol. 30, no. 5, pp. 373–379, 2001.
View at: Publisher Site | Google Scholar
P. Warnke, I. Springer, P. J. Wiltfang et al., “Growth and transplantation of a custom vascularised bone graft in a man,” The Lancet, vol. 364, no. 9436, pp. 766–770, 2004.
View at: Publisher Site | Google Scholar
J. M. Finley, R. D. Acland, and M. B. Wood, “Revascularized periosteal grafts—a new method to produce functional new bone without bone grafting,” Plastic and Reconstructive Surgery, vol. 61, no. 1, pp. 1–6, 1978.
View at: Google Scholar
C. L. Puckett, J. S. Hurvitz, M. H. Metzler, and D. Silver, “Bone formation by revascularized periosteal and bone grafts, compared with traditional bone grafts,” Plastic and Reconstructive Surgery, vol. 64, no. 3, pp. 361–365, 1979.
View at: Google Scholar
M. C. Romana and A. C. Masquelet, “Vascularized periosteum associated with cancellous bone graft: an experimental study,” Plastic and Reconstructive Surgery, vol. 85, no. 4, pp. 587–592, 1990.
View at: Google Scholar
L. Kostopoulos and T. Karring, “Role of periosteum in the formation of jaw bone. An experiment in the rat,” Journal of Clinical Periodontology, vol. 22, no. 3, pp. 247–254, 1995.
View at: Google Scholar
T. Skoog, “The use of periosteum and Surgicel for bone restoration in congenital clefts of the maxilla. A clinical report and experimental investigation,” Scandinavian Journal of Plastic and Reconstructive Surgery, vol. 1, no. 2, pp. 113–130, 1967.
View at: Google Scholar
H. Yajima, S. Tamai, H. Ishida, and O. Kisanuki, “Prefabricated vascularized periosteal grafts using fascial flap transfers,” Journal of Reconstructive Microsurgery, vol. 11, no. 3, pp. 201–205, 1995.
View at: Google Scholar
H. Ishida, S. Tamai, H. Yajima, K. Inoue, H. Ohgushi, and Y. Dohi, “Histologic and biochemical analysis of osteogenic capacity of vascularized periosteum,” Plastic and Reconstructive Surgery, vol. 97, no. 3, pp. 512–518, 1996.
View at: Google Scholar
G. Payement, M. Therin, C. Dansard, and E. Delay, “Osteogenic capacity of a vascularized periosteal flap tubulized around a coral implant. Experimental study on sheep,” Annales de Chirurgie Plastique Esthétique, vol. 41, no. 6, pp. 651–659, 1996.
View at: Google Scholar
I. Ono, H. Gunji, K. Suda et al., “Bone induction of hydroxyapatite combined with bone morphogenetic protein and covered with periosteum,” Plastic and Reconstructive Surgery, vol. 95, no. 7, pp. 1265–1272, 1995.
View at: Google Scholar
A. S. Breitbart, D. A. Grande, R. Kessler, J. T. Ryaby, R. J. Fitzsimmons, and R. T. Grant, “Tissue engineered bone repair of calvarial defects using cultured periosteal cells,” Plastic and Reconstructive Surgery, vol. 101, no. 3, pp. 567–576, 1998.
View at: Publisher Site | Google Scholar
E. Vögelin, N. F. Jones, J. R. Lieberman, J. M. Baker, A. S. Tsingotjidou, and J. H. Brekke, “Prefabrication of bone by use of a vascularized periosteal flap and bone morphogenetic protein,” Plastic and Reconstructive Surgery, vol. 109, no. 1, pp. 190–198, 2002.
View at: Google Scholar
U. Kneser, E. Polykandriotis, J. Ohnolz et al., “Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop,” Tissue Engineering, vol. 12, no. 7, pp. 1721–1731, 2006.
View at: Publisher Site | Google Scholar
E. Polykandriotis, A. Arkudas, R. E. Horch, M. Stürzl, and U. Kneser, “Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science,” Journal of Cellular and Molecular Medicine, vol. 11, no. 1, pp. 6–20, 2007.
View at: Publisher Site | Google Scholar
T. Nakasa, O. Ishida, T. Sunagawa et al., “Feasibility of prefabricated vascularized bone graft using the combination of FGF-2 and vascular bundle implantation within hydroxyapatite for osteointegration,” Journal of Biomedical Materials Research Part A, vol. 85, no. 4, pp. 1090–1095, 2008.
View at: Google Scholar
K. Kawamura, H. Yajima, H. Ohgushi et al., “Experimental study of vascularized tissue-engineered bone grafts,” Plastic and Reconstructive Surgery, vol. 117, no. 5, pp. 1471–1479, 2006.
View at: Publisher Site | Google Scholar
O. C. S. Cassell, S. O. P. Hofer, W. A. Morrison, and K. R. Knight, “Vascularization of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states,” British Journal of Plastic Surgery, vol. 55, no. 8, pp. 603–610, 2002.
View at: Publisher Site | Google Scholar
P. Pelissier, F. Villars, S. Mathoulin-Pelissier, R. Bareille, M.-H. Lafage-Proust, and J. Vilamitjana-Amedee, “Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats,” Plastic and Reconstructive Surgery, vol. 111, no. 6, pp. 1932–1941, 2003.
View at: Publisher Site | Google Scholar
Y. Tanaka, K.-C. Sung, A. Tsutsumi, S. Ohba, K. Ueda, and W. A. Morrison, “Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation?” Plastic and Reconstructive Surgery, vol. 112, no. 6, pp. 1636–1644, 2003.
View at: Publisher Site | Google Scholar
O. O. Erol and M. Spira, “New capillary bed formation with a surgically constructed arteriovenous fistula,” Surgical Forum, vol. 30, pp. 530–531, 1979.
View at: Google Scholar
O. C. S. Cassell, W. A. Morrison, A. Messina et al., “The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue,” Annals of the New York Academy of Sciences, vol. 944, pp. 429–442, 2001.
View at: Google Scholar
A. Arkudas, J. P. Beier, K. Heidner et al., “Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts,” Tissue Engineering, vol. 13, no. 7, pp. 1549–1560, 2007.
View at: Publisher Site | Google Scholar
L.-L. Ren, D.-Y. Ma, X. Feng, T.-Q. Mao, Y.-P. Liu, and Y. Ding, “A novel strategy for prefabrication of large and axially vascularized tissue engineered bone by using an arteriovenous loop,” Medical Hypotheses, vol. 71, no. 5, pp. 737–740, 2008.
View at: Publisher Site | Google Scholar
C. M. Serre, D. Farlay, P. D. Delmas, and C. Chenu, “Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers,” Bone, vol. 25, no. 6, pp. 623–629, 1999.
View at: Publisher Site | Google Scholar
E. L. Hohmann, R. P. Elde, and J. A. Rysavy, “Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers,” Science, vol. 232, no. 4752, pp. 868–871, 1986.
View at: Google Scholar
S. Imai, Y. Tokunaga, T. Maeda, M. Kikkawa, and S. Hukuda, “Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: an immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms,” Journal of Orthopaedic Research, vol. 15, no. 1, pp. 133–140, 1997.
View at: Google Scholar
G. Sisask, A. Bjurholm, M. Ahmed, and A. Kreicbergs, “The development of autonomic innervation in bone and joints of the rat,” Journal of the Autonomic Nervous System, vol. 59, no. 1-2, pp. 27–33, 1996.
View at: Google Scholar
A. Sakai, S. Nishida, N. Okimoto et al., “Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice,” Bone, vol. 23, no. 5, pp. 443–451, 1998.
View at: Publisher Site | Google Scholar
B. Chen, G.-X. Pei, D. Jin, K.-H. Wei, Y. Qin, and Q.-S. Liu, “Distribution and property of nerve fibers in human long bone tissue,” Chinese Journal of Traumatology, vol. 10, no. 1, pp. 3–9, 2007.
View at: Google Scholar
I. Kjaer, “Correlated appearance of ossification and nerve tissue in human fetal jaws,” Journal of Craniofacial Genetics and Developmental Biology, vol. 10, no. 3, pp. 329–336, 1990.
View at: Google Scholar
I. Kjaer, “Neuro-osteology,” Critical Reviews in Oral Biology & Medicine, vol. 9, no. 2, pp. 224–244, 1998.
View at: Google Scholar
B. Lanske, M. Amling, L. Neff, J. Guiducci, R. Baron, and H. M. Kronenberg, “Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development,” Journal of Clinical Investigation, vol. 104, no. 4, pp. 399–407, 1999.
View at: Google Scholar
A. Bjurholm, “Neuroendocrine peptides in bone,” International Orthopaedics, vol. 15, no. 4, pp. 325–329, 1991.
View at: Google Scholar
E. L. Hill and R. Elde, “Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat,” Cell and Tissue Research, vol. 264, no. 3, pp. 469–480, 1991.
View at: Google Scholar
A. Togari, M. Arai, S. Mizutani, S. Mizutani, Y. Koshihara, and T. Nagatsu, “Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells,” Neuroscience Letters, vol. 233, no. 2-3, pp. 125–128, 1997.
View at: Google Scholar
M. Ransjö, A. Lie, H. Mukohyama, P. Lundberg, and U. H. Lerner, “Microisolated mouse osteoclasts express VIP-1 and PACAP receptors,” Biochemical and Biophysical Research Communications, vol. 274, no. 2, pp. 400–404, 2000.
View at: Publisher Site | Google Scholar
U. H. Lerner and E. Persson, “Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide,” Journal of Musculoskeletal Neuronal Interactions, vol. 8, no. 2, pp. 154–165, 2008.
View at: Google Scholar
J. Cornish, K. E. Gallon, C. Q. Lin et al., “Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts,” Journal of Bone and Mineral Research, vol. 14, no. 8, pp. 1302–1309, 1999.
View at: Publisher Site | Google Scholar
S. M. D'Souza, I. MacIntyre, S. I. Girgis, and G. R. Mundy, “Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro,” Endocrinology, vol. 119, no. 1, pp. 58–61, 1986.
View at: Google Scholar
H. Drissi, M. Lieberherr, M. Hott, P. J. Marie, and F. Lasmoles, “Calcitonin gene-related peptide (CGRP) increases intracellular free Ca²⁺ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4),” Cytokine, vol. 11, no. 3, pp. 200–207, 1999.
View at: Publisher Site | Google Scholar
I. Villa, C. Dal Fiume, A. Maestroni, A. Rubinacci, F. Ravasi, and F. Guidobono, “Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity,” American Journal of Physiology, vol. 284, no. 3, pp. E627–E633, 2003.
View at: Google Scholar
A. Vignery and T. L. McCarthy, “The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts,” Bone, vol. 18, no. 4, pp. 331–335, 1996.
View at: Google Scholar
G. D. Roodman, “Mechanisms of bone metastasis,” The New England Journal of Medicine, vol. 350, no. 16, pp. 1655–1698, 2004.
View at: Publisher Site | Google Scholar
S. R. Haug and K. J. Heyeraas, “Modulation of dental inflammation by the sympathetic nervous system,” Journal of Dental Research, vol. 85, no. 6, pp. 488–495, 2006.
View at: Publisher Site | Google Scholar
N. J. Lee and H. Herzog, “NPY regulation of bone remodelling,” Neuropeptides, vol. 43, no. 6, pp. 457–463, 2009.
View at: Publisher Site | Google Scholar
W. Deng, T. J. Bivalacqua, N. N. Chattergoon, J. R. Jeter Jr., and P. J. Kadowitz, “Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector,” Stem Cells, vol. 22, no. 7, pp. 1279–1291, 2004.
View at: Publisher Site | Google Scholar
J. N. De Hoon, P. Pickkers, P. Smits, H. A. J. Struijker-Boudier, and L. M. A. B. Van Bortel, “Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans,” Clinical Pharmacology and Therapeutics, vol. 73, no. 4, pp. 312–321, 2003.
View at: Publisher Site | Google Scholar
Y. Hirata, Y. Takagi, S. Takata, Y. Fukuda, H. Yoshima, and T. Fujita, “Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells,” Biochemical and Biophysical Research Communications, vol. 151, no. 3, pp. 1113–1121, 1988.
View at: Google Scholar
X. Qing and I. M. Keith, “Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats,” American Journal of Physiology, vol. 285, no. 1, pp. L86–L96, 2003.
View at: Google Scholar
J. Clarke, N. Benjamin, S. Larkin, D. Webb, A. Maseri, and G. Davies, “Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man,” Circulation, vol. 83, no. 3, pp. 774–777, 1991.
View at: Google Scholar
B. E. Lindblad, L. B. Nielsen, S. M. Jespersen, A. Bjurholm, C. Bunger, and E. S. Hansen, “Vasoconstrictive action of neuropeptide Y in bone: the porcine tibia perfused in vivo,” Acta Orthopaedica Scandinavica, vol. 65, no. 6, pp. 629–634, 1994.
View at: Google Scholar
P. W. Ackermann, J. Li, A. Finn, M. Ahmed, and A. Kreicbergs, “Autonomic innervation of tendons, ligaments and joint capsules. A morphologic and quantitative study in the rat,” Journal of Orthopaedic Research, vol. 19, no. 3, pp. 372–378, 2001.
View at: Publisher Site | Google Scholar
P. W. Ackermann, A. Finn, and M. Ahmed, “Sensory neuropeptidergic pattern in tendon, ligament and joint capsule. A study in the rat,” NeuroReport, vol. 10, no. 10, pp. 2055–2060, 1999.
View at: Google Scholar
Q.-S. Wang, G.-X. Pei, S. Jinag et al., “Effect of rabbit peripheral sensory and motor nerve homogenates on the proliferation and calcification of rabbit osteoblasts in vitro,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 28, no. 5, pp. 774–778, 2008.
View at: Google Scholar
S. Chen, J. Qin, T. Mu et al., “Effect of tissue engineered bone implantation with vascular bundle and sensory nerve bundle on expression of neurokinin 1 receptor and vasoactive intestinal peptide type 1 receptor in vivo,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 24, no. 7, pp. 785–791, 2010.
View at: Google Scholar
M. Kosaka, “Enhancement of rat peripheral nerve regeneration through artery-including silicone tubing,” Experimental Neurology, vol. 107, no. 1, pp. 69–77, 1990.
View at: Publisher Site | Google Scholar
T. D. Palmer, A. R. Willhoite, and F. H. Gage, “Vascular niche for adult hippocampal neurogenesis,” Journal of Comparative Neurology, vol. 425, no. 4, pp. 479–494, 2000.
View at: Google Scholar

Copyright

Copyright © 2014 Junjun Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1879

Downloads

1110

Citations